Sal Gilbertie, CEO of Teucrium Trading, joins Bilal Little, Director of Exchange Traded Products at the NYSE.

The M&A landscape has rebounded in 2025, driven by stable interest rates, improved market conditions, and rising CEO confidence. Strategic buyers are fueling the surge, targeting deals that boost growth, expand capabilities, and enhance competitive positioning. Houlihan Lokey has emerged as the g...

Structural heart innovation is rewriting the future of cardiovascular care—delivering faster recoveries, better outcomes, and a new standard of precision through less invasive procedures. Breakthroughs in imaging, smarter device design, and real-time data are empowering doctors to tackle even the...

Elanco is transforming pet health with powerful medicines that protect, prevent, and heal. Their innovations help pets live longer, healthier, and happier lives. As a global leader in animal health, Elanco delivers high-quality care at every stage—from puppyhood to senior years. At the helm is CE...